Advertisement BioForce Nanosciences signs collaboration agreement with UPMC and CNRS - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

BioForce Nanosciences signs collaboration agreement with UPMC and CNRS

BioForce Nanosciences Holdings, a developer of innovative nanotech tools and solutions for the life sciences, has signed a scientific collaboration agreement with the University Pierre & Marie Curie and Centre National de Recheche Scientifique in Paris, France.

Under the terms of this agreement, researchers from the laboratory of Fatiha Nothias will collaborate with BioForce to develop technologies, protocols, and products related to neural cell-based assays.

These proprietary assays will be created using the Nano eNabler molecular printer from BioForce, and they will allow scientists to study the structure, function, and microenvironments of neural cells.

Michael Lynch, product manager of BioForce Nanosciences, said: “This collaborative agreement emphasizes our continued interest in supporting cutting edge applications and bringing them to the market as novel products. The biomedical research community has made fantastic advances in a number of areas, however, there are still a great many unknowns in brain research, and deciphering that complexity represents a massive international effort and opportunity.”